Coherus Oncology(FRA) 8C5

Market Cap€190.35M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€1.15

-3.94%

-0.05Today

Coherus Oncology Financials at a Glance

Market Cap

€190.35M

Revenue (TTM)

€43.68

Net Income (TTM)

-€138.16

EPS (TTM)

-€0.88

P/E Ratio

-1.41

Dividend

€0.00

Beta (Volatility)

-0.00 (Low)

Dividend

€0.00

Beta (Volatility)

-0.00 (Low)

Price

€1.15

Volume

Open

€1.15

Price

€1.15

Volume

Open

€1.15

Previous Close

€1.19

Daily Range

€1.15 - €1.15

52-Week Range

€0.94 - €2.19

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.00 (Low)

Price

€1.15

Volume

Open

€1.15

Previous Close

€1.19

Daily Range

€1.15 - €1.15

52-Week Range

€0.94 - €2.19

Estimated Earnings Date

N/A

8C5 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Coherus Oncology

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Industry

Biotechnology

Sector

Health Care

Employees

147

CEO

Denny M. Lanfear, MBA

Website

www.coherus.com

8C5 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-177.94%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-70.92%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€190.35M

Shares Outstanding

154.50M

Volume

Avg. Volume

12.621

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Coherus Oncology Performance Analysis

Coherus Oncology annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 200,806,049	-27.3%
2023	2023-12-31	EUR 237,943,102	18.5%
2024	2024-12-31	EUR 24,396,067	-89.7%
2025	2025-12-31	EUR 37,367,379	53.2%

Coherus Oncology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -3.58	11.1%
2023	2023-12-31	EUR -2.34	-34.7%
2024	2024-12-31	EUR -1.20	-48.9%
2025	2025-12-31	EUR -1.29	7.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€12.30

+1.4%

Gross Profit

€7.92

+1.5%

Gross Margin

64.33%

+1.1%

Market Cap

€190.35M

N/A

Market Cap/Employee

€1.32

N/A

Employees

147

N/A

Net Income

-€28.68

+0.7%

EBITDA

-€27.07

+0.7%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€119.92

-48.1%

Total Debt

€47.39

+1.0%

Accounts Receivable

€12.14

+2.8%

Inventory

€4.96

+1.3%

Long Term Debt

€45.68

+1.0%

Short Term Debt

€1.70

+1.1%

Return on Assets

-51.02%

+1.8%

Return on Invested Capital

-103.65%

N/A

Free Cash Flow

-€53.71

+1.4%

Operating Cash Flow

-€53.71

+1.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About 8C5

What is the current price of Coherus Oncology?

Coherus Oncology is trading at €1.15 per share.

What is the 52-week range for Coherus Oncology?

Over the past 52 weeks, Coherus Oncology has traded between €0.94 and €2.19.

How much debt does Coherus Oncology have?

As of the most recent reporting period, Coherus Oncology reported total debt of €47.39M.

How much cash does Coherus Oncology have on hand?

Coherus Oncology reported €72.53M in cash and cash equivalents in its most recent financial results.

What is Coherus Oncology’s dividend yield?

Coherus Oncology does not currently have a dividend yield.

Coherus Oncology(FRA) 8C5

Coherus Oncology Financials at a Glance

8C5 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Coherus Oncology

8C5 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Coherus Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About 8C5

What is the current price of Coherus Oncology?

What is the 52-week range for Coherus Oncology?

How much debt does Coherus Oncology have?

How much cash does Coherus Oncology have on hand?

What is Coherus Oncology’s dividend yield?

Premium Investing Services